Aberdeen Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $3.24M | Hold |
97,400
| – | – | 0.01% | 540 |
|
|
2017
Q1 | $3.13M | Sell |
97,400
-22,000
| -18% | -$706K | 0.01% | 527 |
|
|
2016
Q4 | $4.33M | Hold |
119,400
| – | – | 0.02% | 460 |
|
|
2016
Q3 | $5.49M | Hold |
119,400
| – | – | 0.02% | 421 |
|
|
2016
Q2 | $6M | Hold |
119,400
| – | – | 0.02% | 393 |
|
|
2016
Q1 | $6.39M | Sell |
119,400
-2,100
| -2% | -$112K | 0.02% | 374 |
|
|
2015
Q4 | $6.8M | Hold |
121,500
| – | – | 0.02% | 368 |
|
|
2015
Q3 | $6.86M | Sell |
121,500
-18,397
| -13% | -$1.04M | 0.02% | 324 |
|
|
2015
Q2 | $8.27M | Hold |
139,897
| – | – | 0.02% | 304 |
|
|
2015
Q1 | $8.72M | Sell |
139,897
-75,982
| -35% | -$4.73M | 0.02% | 276 |
|
|
2014
Q4 | $12.4M | Sell |
215,879
-160,820
| -43% | -$9.25M | 0.03% | 241 |
|
|
2014
Q3 | $20.2M | Sell |
376,699
-25,200
| -6% | -$1.35M | 0.04% | 207 |
|
|
2014
Q2 | $21.1M | Buy |
401,899
+68,982
| +21% | +$3.62M | 0.04% | 213 |
|
|
2014
Q1 | $17.6M | Hold |
332,917
| – | – | 0.05% | 104 |
|
|
2013
Q4 | $13.3M | Buy |
332,917
+13,000
| +4% | +$521K | 0.04% | 116 |
|
|
2013
Q3 | $12.1M | Buy |
319,917
+10,000
| +3% | +$378K | 0.03% | 112 |
|
|
2013
Q2 | $12.1M | Buy |
+309,917
| New | +$12.1M | 0.04% | 103 |
|